On November 30th, the fourth batch of national organized high-value medical consumables centralized procurement with quantity was opened in Tianjin. This centralized procurement is mainly aimed at artificial lens and sports medicine consumables, with an average price reduction of about 70% for the selected products. From the first batch of centralized procurement of cardiac coronary stents in 2020 to the production of artificial joints in 2021, as well as orthopedic spinal consumables in 2022, China has carried out four batches of national high-value medical consumables centralized procurement with volume in more than three years. What are the new features of this high-value medical consumables procurement? Has four batches of high-value medical consumables centralized procurement been carried out, and can both enterprises and the public benefit from it while ensuring quality and quantity? News 1+1: Connect with Gao Xue, Deputy Director of the Joint Procurement Office for High Value Medical Consumables of the National Organization, to jointly pay attention to the fourth batch of centralized procurement for high-value medical consumables! Why did the fourth batch of high-value medical consumables choose artificial lenses and sports medicine consumables for centralized procurement? Gao Xue, Deputy Director of the Joint Procurement Office for High Value Medical Consumables of the National Organization: We choose centralized and quantity based procurement of high-value medical consumables mainly because we choose products with large quantities, high amounts, and demand from the public. The number of cataract patients is already relatively large, and the demand is also very high, so we will include artificial lenses in the fourth batch of volume based procurement. In addition, sports medicine consumables themselves belong to a rapidly developing product, which is also a category in orthopedics. We are also aiming to fill the gap in orthopedic centralized procurement this time, covering all orthopedic consumables through centralized procurement. Therefore, sports medicine products are also included in the fourth batch of centralized volume procurement. Is the enthusiasm of enterprises still high after the reduction of consumable prices? Gao Xue, Deputy Director of the National Organization High Value Medical Consumables Joint Procurement Office: From the current situation, enterprises are actually very active in cooperating with centralized procurement. After centralized volume based procurement, the sales volume and amount of many enterprises are steadily increasing. So from the data, they are constantly supporting procurement. And through the "one product, one policy" procurement process, they can gradually see policy trends and changes in contract volume. We are also helping them ensure the performance and execution of contracts. Including our payment policy, it is very attractive to them. How to ensure product quality for a long time after centralized procurement of consumables? Gao Xue, Deputy Director of the High Value Medical Consumables Joint Procurement Office of the National Organization: After the centralized procurement, we will also continuously carry out quality monitoring, and the drug regulatory department will conduct spot checks to ensure that the quality of the selected products is not a problem. In addition, the sampling work will also be carried out for a long time. It is not just a one-time sampling after winning the bid. We will continuously monitor it, and if there are any problems, we also have the strictest regulatory measures. What other categories may high-value medical consumables be included in the future? Gao Xue, Deputy Director of the High Value Medical Consumables Joint Procurement Office of the National Organization: In the future, there is still more product knowledge that we need to learn. On the basis of continuous learning, we will also incorporate other unreleased products, such as interventional, circulatory, or surgical products, into our procurement thinking and scope, which can also benefit the people more. (Lai Xin She)